Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis

Gao Sheng; Liu JianYong; Zhang ZhiMing; Zhao YinNong; Yuan WeiPing; Wu FeiXiang; Xiang BangDe

doi:10.3969/j.issn.1001-5256.2014.09.020

Issue 9

Sep. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(9): 917-920

PDF( 1961 KB)

Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis

DOI: 10.3969/j.issn.1001-5256.2014.09.020

Department of Hepatobiliary Surgery, Tumor Hospital of Guangxi Medical University

Research funding:

Received Date: 2013-12-30
Published Date: 2014-09-20

Abstract

Abstract

Objective To assess the efficacy of transcatheter arterial chemoembolization ( TACE) in patients with hepatocellular carcinoma ( HCC) before hepatectomy. Methods PubMed, Embase, the Cochrane Library, CNKI, VIP, and Wanfang Data were searched to identify randomized controlled trials ( RCTs) evaluating the efficacy of preoperative TACE plus hepatectomy ( study group) versus hepatectomy alone ( control group) in HCC patients published up to March 12, 2013. The quality of included studies was assessed, and relevant data were extracted. Statistical analysis was performed by RevMan 5. 2. Results A total of 4 RCTs involving 342 participants were included. Meta- analysis of data extracted from the included RCTs showed that there were no significant differences between the study group and control group in 1-, 3-, and 5- year disease- free survival ( DFS) , with relative risks ( RRs) ( 95% confidence intervals ( CIs) ) of 1. 07 ( 0. 92-1. 25) ( P = 0. 38) , 1. 05 ( 0. 79, 1. 41) ( P = 0. 72) , and 0. 95 ( 0. 64- 1. 42) ( P = 0. 81) , respectively, in 1-, 3-, and 5- year overall survival ( OS) , with RRs ( 95% CIs) of 1. 01 ( 0. 92- 1. 10) ( P = 0. 85) , 1. 14 ( 0. 97- 1. 34) ( P = 0. 11) , and 0. 95 ( 0. 75-1. 21) ( P = 0. 68) , respectively, and in rate of postoperative complications and mortality, with RRs ( 95% CIs) of 0. 89 ( 0. 45- 1. 75) ( P= 0. 73) and 0. 77 ( 0. 25- 2. 37) ( P = 0. 65) , respectively. Conclusion TACE before hepatectomy cannot increase DFS and OS and reduce complications and mortality in HCC patients. However, the numbers of studies and cases included in the analysis are small, and more high- quality, large- sample RCTs are needed to confirm the conclusion.
- carcinoma, hepatocellular,
- chemoembolization, therapeutic,
- hepatectomy,
- meta-analysis

FullText(HTML)

References(19)

References

[1]WU CC, HO YZ, HO WL, et al.Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma:a reappraisal[J].Br J Surg, 1995, 82 (1) :122-126.

[2]YAMASAKI S, HASEGAWA H, KINOSHITA H, et al.A prospective randomizedtrial of preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma[J].Jpn J Cancer Res, 1996, 87 (2) :206-211.

[3] ZHOU WP, LAI EC, LI AJ, et al.A prospective, randomized, controlled trial of preoperative transartefial chemoembolization for resectable large hepatocellular carcinoma[J].Ann Surg, 2009, 249 (2) :195-202.

[4] KAIBORI M, TANIGAWA N, KARIYA S, et al.A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma[J].Dig Dis Sci, 2012, 57 (5) :1404-1412.

[5] LLOVET JM, SCHWARTZ M, MAZZAFERRO V, et al.Resection and liver transplantation for hepatocellular carcinoma[J].Semin Liver Dis, 2005, 25 (2) :181-200.

[6] KOW AW, KWON CH, SONG S, et al.Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma:review of 1222 cases of hepatectomy in a tertiary institution[J].Ann Surg Oncol, 2012, 19 (7) :2246-2255.

[7] HO CM, WU CY, LEE PH, et al.Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma[J].Ann Surg Oncol, 2013, 20 (8) :2526-2533.

[8]BREEDIS C, YOUNG Y.The blood supply of neoplasms inthe liver[J].Am J Pathol, 1954, 30 (5) :969-977.

[9]WANG ZX, LI HQ, WANG ZT.The significance of surgery combined with interventional therapy in primary hepatic carcinoma[J].J Med Imaging, 2009, 19 (8) :987-989. (in Chinese) 王振旭, 李红旗, 王振亭.原发性肝癌外科手术联合血管内介入治疗的意义[J].医学影像学杂志, 2009, 19 (8) :987-989.

[10]PU J, WEI ZH, WANG JC, et al.The value of preoperative transcatherter arterial chemoembolization in reducing the lesion-residual rate after hepatecomy of primary hepatocellular carcinoma[J].J Pract Radiol, 2006, 22 (4) :446-452. (in Chinese) 浦涧, 韦忠恒, 汪建初, 等.术前肝动脉化疗栓塞对减少原发性肝癌手术癌残存的意义[J].实用放射学杂志, 2006, 22 (4) :446-452.

[11] SUGO H, FUTAGAWA S, BEPPU T, et al.Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma:relation between postoperative course and the pattern of tumor recurrence[J].World J Surg, 2003, 27 (12) :1295-1299.

[12]LU CD, PENG SY, JIANG XC, et al.Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas:retrospective analysis of 120 cases[J].World J Surg, 1999, 23 (3) :293-300.

[13]ZHANG B, WU LQ.Evaluation of treatment of primary liver cancer-transcatheter arterial chemoembolization before and after hepatectomy in treatment of primary liver cancer[J].Shangdong Med J, 2003, 43 (36) :56. (in Chinese) 张斌, 吴力群.肝切除术前后肝动脉置管化疗栓塞治疗原发性肝癌[J].山东医药, 2003, 43 (36) :56.

[14]YU WS, GUO RP, SHI M, et al.Efficacy of second stage resection following transcatheter hepatic arterial chemoembolization in patients with large hepatocellular carcinoma of hardly radical excision[J].J Sun Yat-Sen Univ:Medical Sciences, 2007, 28 (6) :709-713. (in Chinese) 俞武生, 郭荣平, 石明, 等.难以根治性切除大肝癌经皮肝动脉化疗栓塞术后二期切除的疗效分析[J].中山大学学报:医学科学版, 2007, 28 (6) :709-713.

[15]ZHOU JP, ZHOU WP, CONG WM, et al.Pathological study of resected specimens of resectable large hepatocellular carcinoma after transcatheter arterial chemoembolization[J].J Hepatobiliary Surg, 2004, 12 (1) :11-13. (in Chinese) 周建平, 周伟平, 丛文铭, 等.大肝癌TACE后手术切除标本的病理研究[J].肝胆外科杂志, 2004, 12 (1) :11-13.

[16]ZHU WB, LI CL, FANG XJ, et al.Preventive effects of perioperative transarterial chemoembolization on recurrence of large hepatocellular carcinoma[J].Chin J Hepatobiliary Surg, 2001, 7 (4) :208-230. (in Chinese) 朱玮冰, 李朝龙, 方学军, 等.围手术期肝动脉栓塞化疗预防大肝癌术后复发的作用初探[J].中华肝胆外科杂志, 2001, 7 (4) :208-230.

[17]LUO YQ, WANG Y, CHEN H, et al.Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma[J].Chin J Gen Surg, 2002, 17 (3) :149-151. (in Chinese) 罗运权, 王义, 陈汉, 等.可切除肝癌术前经肝动脉化学药物栓塞对肝切除手术的影响[J].中华普通外科杂志, 2002, 17 (3) :149-151.

[18] HARADA T, MATSUO K, INOUE T, et al.Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?[J].Ann Surg, 1996, 224 (1) :4-9.

[19]HUANG J, HE X, LIN X, et al.Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma[J].Chin Med J (Engl) , 2000, 113 (5) :446-448.引证本文:GAO S, LIU JY, ZHANG ZM, et al.Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis[J].J Clin Hepatol, 2014, 30 (9) :917-920. (in Chinese) 高胜, 刘剑勇, 张志明, 等.肝细胞癌切除术前应用肝动脉化疗栓塞术疗效的Meta分析[J].临床肝胆病杂志, 2014, 30 (9) :917-920.

Relative Articles

[1]	Zhiran YANG, Linheng WANG, Yuan LI, Fusheng LIU, Yu WANG, Jianfang WANG, Runhua CHEN. Diagnostic value of transient elastography in the staging of hepatic fibrosis in patients with autoimmune liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(1): 97-103. doi: 10.3969/j.issn.1001-5256.2022.01.015
[2]	Liangliang GAN, Jinzhou ZHANG, Xiandong WANG, Caihong FU, Jia SU, Xuemei TANG. Efficacy of artificial liver support system in treatment of acute-on-chronic liver failure: A network Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(1): 135-140. doi: 10.3969/j.issn.1001-5256.2022.01.021
[3]	Fei LIU, Hai LI, Qiang WU. Risk factors for bile leakage after hepatectomy without biliary reconstruction: A Meta - analysis[J]. Journal of Clinical Hepatology, 2022, 38(3): 594-600. doi: 10.3969/j.issn.1001-5256.2022.03.019
[4]	Xin DAI, Hanlin LIU, Long CHENG, Zhulin LUO, Tao WANG. Association of programmed death-1 and programmed death-ligand 1 with the prognosis and clinical features of patients with hepatocellular carcinoma: A meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1577-1583. doi: 10.3969/j.issn.1001-5256.2022.07.022
[5]	Tingpeng HU, Sudan TANG, Zebo YU. Relationship between vitamin D level in children and adolescents with nonalcoholic fatty liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(3): 627-631. doi: 10.3969/j.issn.1001-5256.2021.03.024
[6]	Weiming YU, Wenqian HONG, Binglun SUN, Jingzhao HAN, Hongfang TUO. Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(11): 2575-2583. doi: 10.3969/j.issn.1001-5256.2021.11.018
[7]	Huaqiang ZHANG, Lixin LIU, Xiaohong GUO. Association of nonalcoholic fatty liver disease with the risk of colorectal adenoma and colorectal cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(7): 1619-1625. doi: 10.3969/j.issn.1001-5256.2021.07.028
[8]	Ying LIU, Benjian GAO, Xiaoli YANG, Cheng FANG, Song SU, Bo LI. Effect of hemihepatic vascular exclusion versus total hepatic vascular exclusion in hepatectomy for primary liver cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(1): 73-78. doi: 10.3969/j.issn.1001-5256.2021.01.015
[9]	Shun ZHU, Zhiguo LI, Shuo LI, Xu CAO, Xiaobin LI, Xiaoke LI, Yongan YE. Effect of aspirin on the incidence rate of liver cancer in patients with viral hepatitis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(5): 1097-1102. doi: 10.3969/j.issn.1001-5256.2021.05.024
[10]	Quan ZHOU, Lihui YANG, Fangqing JIANG. Long-term prognosis of patients with hepatitis C virus-related hepatocellular carcinoma receiving direct-acting antiviral: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(8): 1836-1840. doi: 10.3969/j.issn.1001-5256.2021.08.018
[11]	Minjun LI, Zhujian DENG, Haotian LIU, Yuxian TENG, Rongrui HUO, Xiumei LIANG, Bangde XIANG, Lequn LI, Jianhong ZHONG. Clinical effect of re-hepatic resection versus radiofrequency ablation in treatment of recurrent hepatocellular carcinoma in Asia: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(5): 1103-1109. doi: 10.3969/j.issn.1001-5256.2021.05.025
[12]	Yisheng PENG, Pan HE, Gang ZHU, Xinkai LI, Shunde TAN, Jianfei CHEN, Jun FAN, Bin LUO, Song SU, Bo LI, Xiaoli YANG. Efficacy and safety of CalliSpheres microsphere versus conventional transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(8): 1841-1847. doi: 10.3969/j.issn.1001-5256.2021.08.019
[13]	Liu ShenShen, Xing YiQing, Wang Ning, Yu QiaoLing, Ceng LePing. Clinical effect of vitamin E in treatment of nonalcoholic fatty liver disease in children: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(7): 1545-1550. doi: 10.3969/j.issn.1001-5256.2020.07.019
[14]	Tian Bing, Li Fan, Deng BaoCheng. Clinical effect of artificial liver support system in treatment of drug-induced liver failure: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(4): 823-828. doi: 10.3969/j.issn.1001-5256.2020.04.023
[15]	Wang XiangHong, Ma BaoHua, Zou XiuLan, Yao KeCheng, He Qian. Association between nonalcoholic fatty liver disease and epicardial adipose tissue: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(6): 1304-1309. doi: 10.3969/j.issn.1001-5256.2020.06.023
[16]	Qian Le, Ying Li. Selection of second-line drugs for adult autoimmune hepatitis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(9): 2015-2020. doi: 10.3969/j.issn.1001-5256.2020.09.021
[17]	Sun DongXue, Yang Zhu, Long FengXi, Wei XianMan, Tang DongXin. Efficacy and safety of Kanglaite injection combined with transarterial chemoembolization in treatment of advanced liver cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(2): 363-368. doi: 10.3969/j.issn.1001-5256.2020.02.026
[18]	Tang JinQuan, He Pan, Su Song, Luo Bin, Fang Cheng, Li Bo, Xia XianMing, Li YuWei. Short-and long-term effects of radiofrequency ablation versus minimally invasive hepatectomy in treatment of small hepatocellular carcinoma: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(2): 358-362. doi: 10.3969/j.issn.1001-5256.2020.02.025
[19]	Wang Le, Liu LiXin, Guo XiaoHong. Value of contrast-enhanced endoscopic ultrasonography in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2246-2251. doi: 10.3969/j.issn.1001-5256.2019.10.023
[20]	Li Dong, Luo TianYang, Ran YaWei. Value of contrast-enhanced computed tomography and magnetic resonance imaging in diagnosis of residual or recurrent lesion after transcatheter arterial chemoembolization in hepatocellular carcinoma:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2214-2219. doi: 10.3969/j.issn.1001-5256.2019.10.017

Supplements(0)

Cited By

Cited by

Periodical cited type(4)

1.	白丽萍，张颖慧，杨雪艳，白丽仙，马志坚. 昆明地区HBsAg与抗-HBs双阳性慢性HBV感染患者流行病学调查及PreS/S基因突变特征. 西部医学. 2023(12): 1793-1797 .
2.	颜建飞，陈方红，卢伟业，陈志辉，潜潇. 超声造影LI-RADS在隐匿性乙肝患者肝细胞癌诊断中的应用. 温州医科大学学报. 2022(10): 818-822 .
3.	雷泽慧. 增强CT诊断肝细胞癌肾上腺腺瘤与转移瘤的价值分析. 实用医学影像杂志. 2021(01): 55-57 .
4.	钟霞，潘建华，童坚. 海南某院孕妇HBV、HCV和梅毒螺旋体检测结果分析. 传染病信息. 2021(02): 160-161 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2681) PDF downloads(612)

Efficacy of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma before hepatectomy:a meta-analysis

DOI: 10.3969/j.issn.1001-5256.2014.09.020